Search Results - Gissette Reyes‐Soffer
- Showing 1 - 15 results of 15
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Effects of mipomersen, an apolipoprotein B100 antisense, on lipoprotein (a) metabolism in healthy subjects by Renu Nandakumar, Anastasiya Matveyenko, Tiffany Thomas, Marianna Pavlyha, Colleen Ngai, Stephen Holleran, Rajasekhar Ramakrishnan, Henry N. Ginsberg, Wahida Karmally, Santica M. Marcovina, Gissette Reyes‐Soffer
Published 2018Artigo -
9
Effects of <i>APOC3</i> Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism by Gissette Reyes‐Soffer, Carol Sztalryd, Richard B. Horenstein, Stephen Holleran, Anastasiya Matveyenko, Tiffany Thomas, Renu Nandakumar, Colleen Ngai, Wahida Karmally, Henry N. Ginsberg, Rajasekhar Ramakrishnan, Toni I. Pollin
Published 2018Artigo -
10
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association by Gissette Reyes‐Soffer, Henry N. Ginsberg, Lars Berglund, P. Barton Duell, Sean Heffron, Pia R. Kamstrup, Donald M. Lloyd‐Jones, Santica M. Marcovina, Calvin Yeang, Marlys L. Koschinsky
Published 2021Revisão -
11
Adipose Tissue Inflammation and Adiponectin Resistance in Patients With Advanced Heart Failure by Raffay Khan, Tomoko S. Kato, Aalap Chokshi, Michael Chew, Shuiqing Yu, Christina Wu, Parvati Singh, Faisal H. Cheema, Hiroo Takayama, Collette R. Harris, Gissette Reyes‐Soffer, Ralph Knöll, Hendrik Milting, Yoshifumi Naka, Donna Mancini, P. Christian Schulze
Published 2012Artigo -
12
NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis by Sotirios Tsimikas, Sergio Fazio, Keith C. Ferdinand, Henry N. Ginsberg, Marlys L. Koschinsky, Santica M. Marcovina, Patrick M. Moriarty, Daniel J. Rader, Alan T. Remaley, Gissette Reyes‐Soffer, Raúl D. Santos, George Thanassoulis, Joseph L. Witztum, S. Narasimhan Danthi, Michelle Olive, Lijuan Liu
Published 2018Revisão -
13
CETP (Cholesteryl Ester Transfer Protein) Inhibition With Anacetrapib Decreases Production of Lipoprotein(a) in Mildly Hypercholesterolemic Subjects by Tiffany Thomas, Haihong Zhou, Wahida Karmally, Rajasekhar Ramakrishnan, Stephen Holleran, Yang Liu, Patricia Jumes, John A. Wagner, Brian K. Hubbard, Stephen F. Previs, Thomas P. Roddy, Amy O. Johnson‐Levonas, David E. Gutstein, Santica M. Marcovina, Daniel J. Rader, Henry N. Ginsberg, John S. Millar, Gissette Reyes‐Soffer
Published 2017Artigo -
14
Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects by John S. Millar, Gissette Reyes‐Soffer, Patricia Jumes, Richard L. Dunbar, Emil M. deGoma, Amanda Baer, Wahida Karmally, Daniel S. Donovan, Hashmi Rafeek, Laura Pollan, Junichiro Tohyama, Amy O. Johnson‐Levonas, John A. Wagner, Stephen Holleran, Joseph C. Obunike, Yang Liu, Rajasekhar Ramakrishnan, Michael E. Lassman, David E. Gutstein, Henry N. Ginsberg, Daniel J. Rader
Published 2015Artigo -
15
Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy Humans by Gissette Reyes‐Soffer, Marianna Pavlyha, Colleen Ngai, Tiffany Thomas, Stephen Holleran, Rajasekhar Ramakrishnan, Wahida Karmally, Renu Nandakumar, Nelson Fontanez, Joseph C. Obunike, Santica M. Marcovina, Alice H. Lichtenstein, Nirupa R. Matthan, James F. Matta, M. Maroccia, Frederic Becue, Franck Poitiers, Brian N. Swanson, Lisa N. Cowan, William J. Sasiela, Howard K. Surks, Henry N. Ginsberg
Published 2016Artigo
Search Tools:
Related Subjects
Medicine
Cholesterol
Internal medicine
Lipoprotein
Apolipoprotein B
Endocrinology
Lipoprotein(a)
Biology
Disease
Biochemistry
Atherosclerotic cardiovascular disease
Bioinformatics
Chemistry
Intensive care medicine
Very low-density lipoprotein
Cholesterylester transfer protein
Diabetes mellitus
Environmental health
Epidemiology
Immunology
Inflammation
LDL receptor
Lipid metabolism
Metabolism
PCSK9
Pathology
Pharmacology
Population
Secretion
Triglyceride